Mayne Pharma Issues More Than 2 Million Employee Performance Rights
MYX: $2.50 -4.94% · MC: $278M
Mayne Pharma Group issued a combined 2.2 million unquoted performance rights under employee incentive schemes, including rights to key management personnel in two of the notices. Vesting is subject to continued employment or, for one tranche, shareholder-return hurdles; the rights carry no voting or dividend rights while held.

Comments